| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 37 |
| 1 | OXALIPLATIN | 23 |
| 2 | DOXORUBICIN | 22 |
| 3 | TACROLIMUS | 22 |
| 4 | MYCOPHENOLATE MOFETIL | 21 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 21 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 7 | TACROLIMUS OINTMENT 0.1% | 20 |
| 8 | PREDNISONE | 19 |
| 9 | SODIUM CHLORIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 1 | SODIUM CARBONATE | 1 | 0.0043 |
| 2 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 3 | ETHIODIZED OIL | 2 | 0.0015 |
| 4 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 6 | SEVOFLURANE | 9 | 0.0011 |
| 7 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 8 | CEFTAZIDIME | 5 | 0.0006 |
| 9 | APOMORPHINE HYDROCHLORIDE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 51 |
| 1 | Corticosteroid [EPC] | 36 |
| 2 | Osmotic Laxative [EPC] | 19 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 4 | General Anesthetic [EPC] | 11 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 6 | Opioid Agonist [EPC] | 11 |
| 7 | Azole Antifungal [EPC] | 10 |
| 8 | Glycopeptide Antibacterial [EPC] | 9 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Anthelmintic [EPC] | 1 | 0.0003 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 4 | General Anesthetic [EPC] | 11 | 0.0003 |
| 5 | Platinum-based Drug [EPC] | 51 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 9 | 0.0001 |
| 7 | Anticholinergic [EPC] | 2 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |